Related Experiment Video

Updated: Apr 15, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

84.8K

Practical management of anticoagulation in patients with atrial fibrillation

Richard J Kovacs1, Greg C Flaker2, Sherry J Saxonhouse3

  • 1Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, Indiana.

Journal of the American College of Cardiology
|April 4, 2015
PubMed

Insights

Managing anticoagulation for atrial fibrillation is complex, requiring a multidisciplinary team approach. This review offers expert recommendations for practical anticoagulation care, focusing on new agents and patient management.

Area of Science:

  • Cardiology
  • Pharmacology
  • Patient Care Management

Background:

  • Anticoagulation therapy for atrial fibrillation (AF) is increasingly complex.
  • New anticoagulant agents and diverse patient populations necessitate evolving management strategies.
  • Care coordination across multiple specialties and care sites is crucial.

Purpose of the Study:

  • To provide expert recommendations for optimizing anticoagulation management in atrial fibrillation patients.
  • To address practical challenges in anticoagulation, including initiation, interruption, and bleeding management.
  • To synthesize key findings from a multidisciplinary expert roundtable.

Main Methods:

  • Convening a roundtable of experts from multiple specialties.
  • Discussing critical aspects of anticoagulation care for atrial fibrillation.
  • Developing consensus-based recommendations on practical management issues.

Main Results:

  • Key findings from the expert roundtable are presented.
  • Focus on practical aspects of anticoagulation for atrial fibrillation.
  • Recommendations cover initiation, interruption, bleeding, and special populations.

Conclusions:

  • Effective anticoagulation for atrial fibrillation requires a collaborative, team-based approach.
  • Expert consensus provides guidance on managing complex anticoagulation scenarios.
  • This review highlights practical strategies for improving patient care in atrial fibrillation.

Keywords:
anticoagulationatrial fibrillationstroke

More Related Videos

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation28:13

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation

Published on: February 26, 2013

34.4K
Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology10:46

Non-fluoroscopic Catheter Tracking for Fluoroscopy Reduction in Interventional Electrophysiology

Published on: May 26, 2015

14.0K

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
471
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.9K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.5K
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
397
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
605